US FDA accepts New Drug Application for GSK’s momelotinib for treatment of myelofibrosis
Regulatory submission included data from the pivotal Momentum phase-III clinical trial that met all primary and key secondary…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Myelofibrosis treatment
US FDA approves CTI BioPharma’s bone marrow cancer drug
The drug, Vonjo (pacritinib), belongs to a class of anti-inflammatory treatments called JAK inhibitors, and will compete with…